Search the Newsreel

Fulcrum Therapeutics: director Kevin Tang buys $594k in shares

Kevin Tang, a director and 10% owner of Fulcrum Therapeutics, recently purchased 167,616 shares worth approximately $594,675 over two days in mid-July 2026. This insider buying occurs as FULC stock is significantly down year-to-date and below its 52-week high, following the discontinuation of its …

H. B. Fuller Company (NYSE:FUL) Receives Average Rating of "Moderate Buy" from Analysts

Fulton Financial (FULT) To Report Earnings Tomorrow: Here Is What To Expect

Fulton Financial (FULT) To Report Earnings Tomorrow: Here Is What To Expect Regional banking company Fulton Financial (NASDAQ:FULT) will be reporting earnings this Wednesday after market hours. Here's what to look for. Fulton Financial met analysts' revenue expectations last quarter, reporting revenues of $336.2 …

Fulcrum Therapeutics, Inc. (FULC) insider funds purchase 167,616 shares at ~$3.5

Kevin Tang and affiliated Tang Capital entities, identified as 10% owners of Fulcrum Therapeutics (FULC), indirectly purchased 167,616 shares of common stock on July 16–17, 2026. The shares were acquired at weighted-average prices of $3.56 and $3.52 per share, falling within a trade range …

Fulcrum Therapeutics 10% owner Kevin Tang acquires $594,132 of common shares

Kevin Tang, a 10% owner of Fulcrum Therapeutics through Tang Capital-managed entities, reportedly acquired common shares worth $594,132. The shares were purchased at prices ranging from $3.52 to $3.56, increasing his beneficial ownership to 7,080,945 shares. This information originated from a disclosure filed with …

CFO John Corkrean awarded 221 phantom units at FULLER H B CO (FUL)

John J. Corkrean, Executive VP and CFO of FULLER H B CO (FUL), was granted 221.27 phantom units on July 17, 2026, valued at $56.96 per unit as part of the Key Employee Deferred Compensation Plan. These units, which include dividend equivalents, convert to …

H.B. Fuller Company (NYSE: FUL) extends $800M credit line to 2031

H.B. Fuller Company has refinanced and extended its senior credit facilities, increasing its revolving credit facility to $800 million and extending the maturity of these facilities to July 17, 2031. The amendment also reduces applicable interest rate margins by 25 basis points and led …

H.B. Fuller amends credit agreement, extends $420 million term loan A and $800 million revolver to 2031

H.B. Fuller has amended its February 2023 credit agreement with JPMorgan Chase, effectively refinancing its term A loans at $420 million and its revolving loans at $700 million. The company also increased lender commitments by $100 million, bringing the total revolving facility to $800 …

H.B. Fuller Extends Credit Facility to 2031, Ups Revolver to $800 Million, Lowers Margins

H.B. Fuller (FUL) has amended its senior credit agreement, extending maturities to July 17, 2031, and increasing its revolving credit facility to $800 million, while also reducing interest margins by 25 basis points. Concurrently, the company terminated a $2.09 billion secured bridge credit agreement …

Bessemer Group Inc. Raises Position in H. B. Fuller Company $FUL

Bessemer Group Inc. significantly increased its stake in H. B. Fuller Company (NYSE:FUL) by 30.8% in the first quarter, now holding 130,110 shares valued at approximately $8.0 million. This comes as H. B. Fuller reported strong quarterly results, exceeding analyst expectations with an EPS …

H.B. Fuller publishes scheme document for AMS acquisition

H.B. Fuller has published a scheme document detailing its recommended cash acquisition of Advanced Medical Solutions Group PLC (AMS). The acquisition will proceed via a court-sanctioned scheme of arrangement, with shareholder meetings scheduled for August 12, 2026, for approval. AMS directors unanimously recommend the …

Full House Resorts Q1 2026 Earnings: Smaller-Than-Expected Loss Drives Positive Stock Reaction - Tax Rate Impact

Advanced Medical Solutions Releases Scheme Document for H.B. Fuller Acquisition Ahead of August Shareholder Vote

Advanced Medical Solutions Group plc (AMS) has published its scheme document detailing the recommended cash acquisition by H.B. Fuller Medical Adhesive Technologies Inc. This acquisition, first announced in May 2026 and agreed upon in June 2026, will proceed via a Court-sanctioned scheme. AMS shareholders …

FULT4958567 Bond Profile — Key Metrics

This article provides a key metrics profile for the FULT4958567 bond issued by Fulton Financial Corporation. The bond has a coupon of 5.98% and matures on March 15, 2030, with an issue date of March 3, 2020. Fulton Financial Corp. is described as a …

HB Fuller declares $0.245 dividend

H.B. Fuller Company (NYSE: FUL) has declared a regular quarterly cash dividend of $0.245 per common share. This dividend is payable on August 1, 2024, to shareholders of record as of the close of business on July 18, 2024.

(FLGT) Movement Within Algorithmic Entry Frameworks

This article analyzes Fulgent Genetics Inc. (NASDAQ: FLGT) using algorithmic frameworks, highlighting mixed sentiment and a mid-channel oscillation pattern. It presents three distinct trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—tailored for different risk profiles, along with multi-timeframe signal analysis. The report also notes …

Full House Resorts (NASDAQ:FLL) Raised to Hold at Wall Street Zen

Wall Street Zen has upgraded Full House Resorts (NASDAQ:FLL) from a "sell" to a "hold" rating, while Weiss Ratings reiterated a "sell" rating. The company's shares recently dropped 4.4% and opened at $2.40, trading below its 50-day and 200-day moving averages. Despite beating EPS …

BlackRock Portfolio Management LLC discloses 6.0% holding in THERAPEUTICS INC (FULC)

BlackRock Portfolio Management LLC has reported a passive ownership stake of 6.0% in THERAPEUTICS INC (FULC), holding 4,021,379 shares as of June 30, 2026. The firm has sole voting power over 3,604,410 shares and sole dispositive power over all 4,021,379 shares, with no individual …

H. B. Fuller Company Plans Quarterly Dividend of $0.24 (NYSE:FUL)

H. B. Fuller Company (NYSE:FUL) announced a quarterly dividend of $0.245 per share, payable on August 13th to shareholders of record on July 30th. The company boasts a strong dividend track record, with 57 consecutive years of annual increases and a low payout ratio …

Press Release: H.B. Fuller Announces Quarterly Dividend

H.B. Fuller (NYSE: FUL) has announced that its Board of Directors has declared a regular quarterly cash dividend of $0.19 per share. This dividend is payable on August 06, 2026, to shareholders of record at the close of business on July 23, 2026. The …

Kaplan Fox Encourages Investors of Fulcrum Therapeutics, Inc. (NASDAQ: FULC) to Contact the Firm to Learn About Their Legal Rights

Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Fulcrum Therapeutics, Inc. (NASDAQ: FULC) after the company announced the discontinuation of its pociredir program for sickle cell disease. This decision followed FDA concerns regarding the drug's benefit-risk profile, leading to a significant …

HB Fuller (FUL) awards director Thomas Handley 2,894.74 deferred stock units

HB Fuller director Thomas W. Handley received a grant of 2,894.74 stock units on July 15, 2026, with a reference price of $57.00 per unit. These units, part of a deferred compensation plan, will convert into common stock on a 1-for-1 basis upon specific …

H.B. Fuller (FUL) director Michael J. Happe awarded 2,894.7400 stock units

Michael J. Happe, a director at H.B. Fuller (FUL), was awarded 2,894.7400 stock units on July 15, 2026, priced at $57.00 per unit, as part of a deferred compensation plan. This transaction increased his direct stock unit balance to 17,769.0300, in addition to 1,343.0000 …

H.B. Fuller stock trades on its latest report and market data

This article discusses H.B. Fuller (FUL) stock, analyzing its performance based on the latest reported operating figures and current market data as of July 16, 2026. It emphasizes the importance of combining recent financial disclosures (revenue, profit, margin, guidance) with market context like share …

H.B. Fuller declares quarterly dividend of $0.245 per share

H.B. Fuller Company has announced a quarterly cash dividend of $0.245 per share, payable on August 13, 2026. The company has a history of consistently raising its dividend for 33 consecutive years and has paid quarterly dividends for 58 consecutive years. Despite recent positive …

H.B. Fuller Keeps Quarterly Dividend at $0.2450 per Share, Payable Aug. 13 to Shareholders of Record on July 30

H.B. Fuller Company (FUL) has announced that it will maintain its quarterly dividend at $0.2450 per share. This dividend is scheduled to be paid on August 13 to shareholders who are on record as of July 30. The announcement was made on July 16, …

H.B. Fuller to Pay $0.245 Dividend on Aug. 13

H.B. Fuller Company announced that its Board of Directors declared a regular quarterly cash dividend of $0.2450 per share of common stock. The dividend is payable on August 13, 2026, to shareholders of record at the close of business on July 30, 2026. H.B. …

United Bankshares, Fulton Financial, Home Bancshares, First Busey, and Enterprise Financial Services Shares Skyrocket, What You Need To Know

Form 4 Fulcrum Therapeutics Inc For: 15 July By Investing.com

This article reports on a Form 4 filing for Fulcrum Therapeutics Inc. on July 15. Form 4 is a document that must be filed with the U.S. Securities and Exchange Commission (SEC) whenever there is a change in the ownership of company stock by …

Fulcrum Therapeutics, Inc. (FULC) gains Tang Capital as 10.4% shareholder

Tang Capital Management, LLC and its affiliated entities have reported a 10.4% beneficial ownership stake in Fulcrum Therapeutics, Inc. (FULC), amounting to 6,913,329 shares. This disclosure, made via an amended Schedule 13G/A filing, indicates shared voting and dispositive power over these shares among the …

Kevin Tang buys $891k of Fulcrum Therapeutics stock

Kevin Tang, a 10% owner of Fulcrum Therapeutics (NASDAQ:FULC) and Tang Capital Management LLC, purchased 249,946 shares of the company's common stock for approximately $891,067 between July 13 and July 15, 2026. These transactions occurred while the stock was near its 52-week low, and …

Fulcrum Therapeutics (FULC) holder adds 249,946 shares in open-market buys

Entities associated with Kevin Tang and Tang Capital Management LLC, a ten percent owner of Fulcrum Therapeutics, Inc. (FULC), purchased 249,946 shares of common stock between July 13 and 15, 2026. The shares were acquired in open-market buys at prices ranging from $3.50 to …

Kaplan Fox & Kilsheimer LLP Alerts Fulcrum Therapeutics, Inc. (NASDAQ: FULC) Investors to a Securities Investigation

Kaplan Fox & Kilsheimer LLP has announced a securities investigation into Fulcrum Therapeutics, Inc. (NASDAQ: FULC) following a significant drop in its stock price. This investigation comes after Fulcrum Therapeutics discontinued its pociredir program for sickle cell disease due to the FDA's concerns about …

Earnings Preview: Fulton Financial (FULT) Q2 Earnings Expected to Decline

Fulcrum Therapeutics (FULC) insider reports 6,663,383-share Tang Capital stake

What's Driving Fulcrum Lithium's (ASX: FUL) Share Price Lower?